首页 News 正文

AstraZeneca announced on Tuesday local time that a final agreement has been signed on the proposed acquisition of Gracell, which will add GC012F CAR-T cell therapy to AstraZeneca's expanding cell therapy pipeline.
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

白云追月素 注册会员
  • 粉丝

    0

  • 关注

    0

  • 主题

    39